# DocGo Inc.: Form 10-Q for the period ended Sep 30, 2022

- Company: [DocGo Inc.](/companies/dcgo.md) (CIK 1822359)
- Form: 10-Q
- Filed: 2022-11-08
- Accepted by EDGAR: Nov 8, 2022, 16:26 ET
- Period: 2022-09-30
- Accession: 0001213900-22-070146
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1822359/000121390022070146/f10q0922_docgoinc.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1822359/000121390022070146/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-07-01 to 2022-09-30 | $104.3m | us-gaap:Revenues |
| Revenue | 9 months, 2022-01-01 to 2022-09-30 | $331.7m | us-gaap:Revenues |
| Research and development | 3 months, 2022-07-01 to 2022-09-30 | $1.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2022-01-01 to 2022-09-30 | $3.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2022-07-01 to 2022-09-30 | $4.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2022-01-01 to 2022-09-30 | $21.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2022-07-01 to 2022-09-30 | $401.9k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2022-01-01 to 2022-09-30 | $1.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-07-01 to 2022-09-30 | $2.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2022-01-01 to 2022-09-30 | $23.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-07-01 to 2022-09-30 | $0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2022-01-01 to 2022-09-30 | $0.24 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-07-01 to 2022-09-30 | $0.03 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2022-01-01 to 2022-09-30 | $0.26 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-07-01 to 2022-09-30 | 107,403,135 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2022-01-01 to 2022-09-30 | 109,168,293 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2022-01-01 to 2022-09-30 | $37.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2022-01-01 to 2022-09-30 | $2.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months, 2022-01-01 to 2022-09-30 | $497.8k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-09-30 | $169.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-09-30 | $252.0m | us-gaap:AssetsCurrent |
| Total assets | at 2022-09-30 | $355.9m | us-gaap:Assets |
| Current liabilities | at 2022-09-30 | $71.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-09-30 | $85.1m | us-gaap:Liabilities |
| Current portion of debt | at 2022-09-30 | $680.7k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-09-30 | $264.2m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1822359/000121390022070146/f10q0922_docgoinc.htm

Filed Nov 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-070146. Last ingested by Listed: Nov 14, 2026, 23:06 ET. No prices; not investment advice.
